Clik here to view.
Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of...
OSAKA, Japan & CAMBRIDGE, Mass. & PASADENA, Calif. Takeda (TSE:4502/NYSE:TAK) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced topline results from the Phase 2 SEQUOIA...
View ArticleClik here to view.
Clik here to view.
Vizgen Appoints Paul Rasmussen to Spearhead Recent Expansion of MERSCOPE™ in...
CAMBRIDGE, Mass. Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the appointment of industry veteran...
View ArticleClik here to view.
Clik here to view.
肢体延长专家Dror Paley博士在阿联酋Burjeel Medical City开设在中东的首家诊所
阿联酋阿布扎比 (美国商业资讯)–中东和北非地区领先的私人医疗服务提供商之一Burjeel Holdings与著名骨科医生Dror Paley博士合作，共同在阿联酋开设一家诊所，这也是其在持续关注复杂护理和儿科亚专科方面的又一项举措。Paley中东诊所位于阿布扎比的Burjeel Medical City...
View ArticleClik here to view.
Takeda’s EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China,...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that EXKIVITY® (mobocertinib) has been approved by the National Medical Products Administration (NMPA) of China for the...
View ArticleClik here to view.
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen...
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral...
View ArticleClik here to view.
Neutron Therapeutics Announces Successful Generation of a Neutron Beam for...
BOSTON Neutron Therapeutics (NT), a targeted radiation oncology therapy company developing a comprehensive clinical solution for Boron Neutron Capture Therapy (BNCT), today announced the successful...
View ArticleClik here to view.
New Company, Velsera, Represents Summa Equity’s Vision to Improve Global...
BOSTON & SAN FRANCISCO & STOCKHOLM New company Velsera was announced today at the J.P. Morgan Healthcare Conference in San Francisco, California. The vision for Velsera is supported by...
View ArticleClik here to view.
Mary Kay Inc. Company-Sponsored Foundations Give Millions Supporting Women’s...
DALLAS Throughout 2022, iconic beauty brand Mary Kay—along with its company-sponsored foundations—gave more than 3 million dollars to support women’s causes around the world. This press release...
View ArticleClik here to view.
武田的EXKIVITY® (mobocertinib)获得中国国家药监局批准，成为首个及唯一一个治疗EGFR外显子20插入的非小细胞癌患者的疗法
日本大阪和马萨诸塞州剑桥 (美国商业资讯)–武田(Takeda, TSE:4502/NYSE:TAK)今天宣布，EXKIVITY®...
View ArticleClik here to view.
ニュートロン・セラピューティクスが日本の湘南鎌倉総合病院でBNCT用中性子ビームの発生に成功したと発表
ボストン （ビジネスワイヤ） — ホウ素中性子捕捉療法（BNCT）の包括的な臨床ソリューションを開発している標的放射線がん療法企業のニュートロン・セラピューティクス（NT）は本日、標的材に対する業界有数の陽子線電流37mAでの陽子ビーム生成と、神奈川県の湘南鎌倉総合病院（SKGH）におけるnuBeam®システムでの最初の中性子ビーム生成に成功したと発表しました。...
View ArticleClik here to view.
玫琳凯公司赞助的基金会捐赠数百万美元以支持世界各地的女性事业
达拉斯 (美国商业资讯)–整个2022年，标志性美容品牌玫琳凯及其公司赞助的基金会捐赠了超过300万美元，用于支持世界各地的女性事业。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20230112005766/zh-CN/ Female entrepreneurs in Chuxiong, Yunnan...
View ArticleClik here to view.
メアリー・ケイの企業財団が世界各国で女性の福利の支援に向けて数百万ドルを寄付
ダラス （ビジネスワイヤ） — 象徴的な美容ブランドのメアリー・ケイは、同社が資金提供する財団と共に2022年全体で300万ドル以上を世界各国で女性の福利の支援のために寄付しました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：https://www.businesswire.com/news/home/20230112005768/ja/...
View ArticleClik here to view.
ALiA BioTech’s One-stop Diagnostic Platform Brings Multiplex Testing to the...
HONG KONG Driven by the Covid-19 pandemic, the market for point-of-care testing (POCT) is seen to double in size compared to pre-pandemic levels. In this burgeoning field, multiplexing is the key...
View ArticleClik here to view.
武田薬品のEXKIVITY®（モボセルチニブ）が中国NMPAより承認を取得し、EGFRエクソン20挿入変異陽性NSCLC患者に対する初にして唯一の治療薬となる
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the...
BOCA RATON, Fla. Akron Bio (“Akron”), a leading supplier of critical inputs for cell and gene therapies, today announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has granted...
View ArticleClik here to view.
BeiGene Presents New Research from Tislelizumab Global Development Program at...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, will share clinical data and patient-reported outcomes for...
View ArticleClik here to view.
Longevity Biotech Gero Entered a Research Collaboration With Pfizer to...
SAN FRANCISCO Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for...
View ArticleClik here to view.
アクロン・バイオ、臨床細胞治療薬の製造におけるウイルス不活化ヒトフィブロネクチンの商業化について、日本のPMDAから適格性の確認を受ける
米フロリダ州ボカラトン （ビジネスワイヤ） —...
View Article